financetom
Business
financetom
/
Business
/
Spotify Likely to See 'Mid-Teens' Q1 Revenue Growth, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Spotify Likely to See 'Mid-Teens' Q1 Revenue Growth, UBS Says
Apr 2, 2025 9:26 AM

12:11 PM EDT, 04/02/2025 (MT Newswires) -- Spotify ( SPOT ) is expected to post continued mid-teens revenue growth and annual margin expansion in Q1, though at a slower pace, due to new investments, UBS said in a Tuesday note.

UBS analysts said revenue growth may slow in the short term due to the effects of past price hikes and macro pressures in the advertising market.

"However, we continue to believe Spotify ( SPOT ) looks positioned well to benefit from its scale in global distribution," they said.

The analysts pointed to catalysts that can drive monetization and margin upside, including new premium and superfan services launch and price increases with new product features.

For Q2, they expect guidance to show continued mid-teens revenue growth and sequentially lower margins.

UBS cuts its price target to $690 from $720 while keeping its buy rating.

Price: 568.22, Change: +16.49, Percent Change: +2.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aalberts N.V.: Aalberts completes acquisition of Grand Venture Technology Limited
Aalberts N.V.: Aalberts completes acquisition of Grand Venture Technology Limited
Oct 30, 2025
Utrecht, 31 October 2025 Aalberts ( AALBF ) completes acquisition of Grand Venture Technology Limited Aalberts ( AALBF ) announces successful completion of the acquisition of Grand Venture Technology Limited (GVT). With its head office in Singapore, GVT operates six facilities across Singapore, Malaysia and China, generating an annual revenue of SGD 160 million in 2024 and an adjusted EBITDA...
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know
Oct 30, 2025
Intensity Therapeutics Inc. ( INTS ) shares are trending on Friday. Check out the current price of INTS stock here.  Shares of the biotechnology company rallied 394.9% in Thursday's regular session after Phase 1/2 clinical trial results for INT230‑6, an intratumoral therapy combining cisplatin and vinblastine sulfate, were published in eBioMedicine, but the gains tapered in after-hours trading to $0.90,...
Corbus Pharmaceuticals Announces Pricing of Public Offering
Corbus Pharmaceuticals Announces Pricing of Public Offering
Oct 30, 2025
NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. ( CRBP ) (“Corbus” or the “Company”), an oncology and obesity company, today announced the pricing of an underwritten public offering of 4,744,231 shares of its common stock at a public offering price of $13.00 per share, and, in lieu of common stock to certain investors, pre-funded warrants...
Form 8.3 - Offeree = Big Yellow Group plc
Form 8.3 - Offeree = Big Yellow Group plc
Oct 31, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Long Pond Capital, LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved